394 related articles for article (PubMed ID: 25448765)
1. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
[TBL] [Abstract][Full Text] [Related]
2. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
[TBL] [Abstract][Full Text] [Related]
3. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
4. Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Wang C; Wang C; Dong H; Wu XM; Wang C; Xia F; Li G; Jia X; He S; Jiang X; Li H; Xu H
Mol Immunol; 2013 Jan; 53(1-2):43-51. PubMed ID: 22796503
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
6. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
7. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
[TBL] [Abstract][Full Text] [Related]
8. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8.
Sánchez-Fernández A; Zandee S; Amo-Aparicio J; Charabati M; Prat A; Garlanda C; Eisenmesser EZ; Dinarello CA; López-Vales R
Theranostics; 2021; 11(1):1-13. PubMed ID: 33391457
[No Abstract] [Full Text] [Related]
9. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.
Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA
Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770
[TBL] [Abstract][Full Text] [Related]
10. Loss of astrocyte polarity marks blood-brain barrier impairment during experimental autoimmune encephalomyelitis.
Wolburg-Buchholz K; Mack AF; Steiner E; Pfeiffer F; Engelhardt B; Wolburg H
Acta Neuropathol; 2009 Aug; 118(2):219-33. PubMed ID: 19533155
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
12. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
Soon D; Tozer D; Altmann D; Tofts P; Miller D
Mult Scler; 2007 Aug; 13(7):884-94. PubMed ID: 17468443
[TBL] [Abstract][Full Text] [Related]
13. Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.
Larochelle C; Lécuyer MA; Alvarez JI; Charabati M; Saint-Laurent O; Ghannam S; Kebir H; Flanagan K; Yednock T; Duquette P; Arbour N; Prat A
Ann Neurol; 2015 Jul; 78(1):39-53. PubMed ID: 25869475
[TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier in cortical multiple sclerosis lesions.
van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
[TBL] [Abstract][Full Text] [Related]
15. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
Huppert J; Closhen D; Croxford A; White R; Kulig P; Pietrowski E; Bechmann I; Becher B; Luhmann HJ; Waisman A; Kuhlmann CR
FASEB J; 2010 Apr; 24(4):1023-34. PubMed ID: 19940258
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod enhances central nervous system barrier functions.
Lühder F; Kebir H; Odoardi F; Litke T; Sonneck M; Alvarez JI; Winchenbach J; Eckert N; Hayardeny L; Sorani E; Lodygin D; Flügel A; Prat A
Neurobiol Dis; 2017 Jun; 102():60-69. PubMed ID: 28235673
[TBL] [Abstract][Full Text] [Related]
19. Disruption of central nervous system barriers in multiple sclerosis.
Alvarez JI; Cayrol R; Prat A
Biochim Biophys Acta; 2011 Feb; 1812(2):252-64. PubMed ID: 20619340
[TBL] [Abstract][Full Text] [Related]
20. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
